ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987

Emory, Children’s Strengthen Ties

May 25, 2001